(Q47252400)

12 January 2018

title

Treatment of concanavalin A-induced hepatitis in mice with low molecular weight heparin (English)

1 reference

12 January 2018

author name string

Hershkoviz R

1

1 reference

12 January 2018

Bruck R

2

1 reference

12 January 2018

Aeed H

3

1 reference

12 January 2018

Shirin H

4

1 reference

12 January 2018

Halpern Z

5

1 reference

12 January 2018

publication date

1 November 1999

1 reference

12 January 2018

published in

Journal of Hepatology

1 reference

12 January 2018

volume

31

1 reference

12 January 2018

issue

5

1 reference

12 January 2018

page(s)

834-840

1 reference

12 January 2018

Purification of heparin-binding growth factors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Analysis of the inhibition of tumour metastasis by sulphated polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Control of angiogenesis with synthetic heparin substitutes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Interaction between glycosaminoglycans, platelets, and leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

A T cell-dependent experimental liver injury in mice inducible by concanavalin A

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Oral heparin results in the appearance of heparin fragments in the plasma of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Proteoglycans: structures and interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Systemic release of interleukin-10 during orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980284-0

7 January 2021

10.1016/S0168-8278(99)80284-0

Identifiers

DOI

1 reference

12 January 2018

1 reference

12 January 2018